Study assessing the impact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infection
Latest Information Update: 14 Sep 2021
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary) ; Ledipasvir (Primary) ; Ombitasvir (Primary) ; Paritaprevir (Primary) ; Ribavirin (Primary) ; Ritonavir (Primary) ; Sofosbuvir (Primary) ; Interferons
- Indications Hepatitis C
- Focus Therapeutic Use
- 14 Sep 2021 New trial record